Literature DB >> 7362398

Marrow aplasia following topical application of chloramphenicol eye ointment.

S M Abrams, T J Degnan, V Vinciguerra.   

Abstract

Chloramphenicol-induced aplastic anemia is well described in the literature following oral use of the drug. Here we describe the first case we are aware of in which chloramphenicol eye ointment resulted in severe aplastic anemia and, subsequently, death. At least two cases of marrow hypoplasia following use of chloramphenicol eyedrops have been described previously in the literature. The absorption route, its possible relation to the pathogenesis of aplastic anemia, and the two types of marrow toxicity associated with chloramphenicol are reviewed. This case emphasizes the necessity for the same careful consideration for the use of topical preparations that one affords the use of parenterally and orally administered medications.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7362398

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

1.  Treatment of corneal abrasions.

Authors:  M Berner
Journal:  Can Fam Physician       Date:  1987-04       Impact factor: 3.275

Review 2.  Ocular chloramphenicol and aplastic anaemia. Is there a link?

Authors:  S A Rayner; R J Buckley
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

3.  Use of chloramphenicol as topical eye medication: time to cry halt?

Authors:  M Doona; J B Walsh
Journal:  BMJ       Date:  1995-05-13

Review 4.  Chloramphenicol in the 1980s.

Authors:  I Shalit; M I Marks
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

5.  Possible association between ocular chloramphenicol and aplastic anaemia--the absolute risk is very low.

Authors:  J R Laporte; X Vidal; E Ballarín; L Ibáñez
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

6.  Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia?

Authors:  C N McGhee; C N Anastas
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

Review 7.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

Review 8.  Systemic reactions to ophthalmic drug preparations.

Authors:  F T Fraunfelder; S M Meyer
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

9.  Ofloxacin compared with chloramphenicol in the management of external ocular infection.

Authors:  A J Bron; G Leber; S N Rizk; H Baig; A R Elkington; G R Kirkby; C Neoh; A Harden; T Leong
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

10.  Blood dyscrasias and topically applied chloramphenicol in ophthalmology.

Authors:  F W Besamusca; L A Bastiaensen
Journal:  Doc Ophthalmol       Date:  1986-12-30       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.